Marcus (MCS) had the lowest return in 2023 by a small-cap US stock when the return was >= 2%, returning 2.1%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Marcus (MCS) | 2023 | 2.08% |
Adient (ADNT) | 2023 | 2.11% |
Nayax (NYAX) | 2023 | 2.25% |
CTO Realty Growth (CTO) | 2023 | 2.43% |
Personalis (PSNL) | 2023 | 2.44% |
Cidara Therapeutics (CDTX) | 2023 | 2.45% |
Southern States Bancshares (SSBK) | 2023 | 2.47% |
Sana Biotechnology (SANA) | 2023 | 2.51% |
Ennis (EBF) | 2023 | 2.76% |
Great Southern Bancorp (GSBC) | 2023 | 2.77% |
Anterix (ATEX) | 2023 | 2.78% |
Central Pacific Financial (CPF) | 2023 | 2.8% |
Enovis (ENOV) | 2023 | 2.83% |
Corsair Gaming (CRSR) | 2023 | 2.84% |
PHINIA (PHIN) | 2023 | 2.87% |
Amplitude (AMPL) | 2023 | 2.91% |
Braskem SA Class A (BAK) | 2023 | 2.92% |
Donegal Group A (DGICA) | 2023 | 2.94% |
Fresh Del Monte Produce (FDP) | 2023 | 3.07% |
Ares Acquisition Corporation II (AACT) | 2023 | 3.37% |
Utz Brands (UTZ) | 2023 | 3.51% |
Bristow (VTOL) | 2023 | 3.55% |
Ribbon Communications (RBBN) | 2023 | 3.57% |
CareDx (CDNA) | 2023 | 3.63% |
Vital Farms (VITL) | 2023 | 3.63% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
